CD44 and lung adenocarcinoma: CD44 polymorphisms may cause changes in the subtype and content of the mRNA and/or protein of CD44. Therefore, whether CD44 genetic polymorphisms, such as rs713330 and rs10836347, directly affect the clinicopathological characteristics of lung adenocarcinoma merits further attention.